The protein Nod2: An innate receptor more complex than previously assumed

Biochemical Pharmacology

Volumn 80, Issue 12, 2010, Pages 2021-2031

  Lecat, Aurore ^a   Piette, Jacques ^a   Legrand Poels, Sylvie ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Crohn's disease; Inflammation; Innate and adaptative immunity; NF kappaB; NLR

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; RIBONUCLEASE L;

ADAPTIVE IMMUNITY; AUTOPHAGY; BACTERIAL INFECTION; CROHN DISEASE; DRUG MECHANISM; GENE MUTATION; HUMAN; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ADAPTIVE IMMUNITY; ANIMALS; AUTOPHAGY; BACTERIAL INFECTIONS; CROHN DISEASE; ENZYME ACTIVATION; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 78049450786     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.07.016     Document Type: Review

References (99)

1. Kawai T., Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 2005, 17:338-344.
2. Dixon M.S., Golstein C., Thomas C.M., van Der Biezen E.A., Jones J.D. Genetic complexity of pathogen perception by plants: the example of Rcr3, a tomato gene required specifically by Cf-2. Proc Natl Acad Sci USA 2000, 97:8807-8814.
3. Inohara N., Koseki T., del Peso L., Hu Y., Yee C., Chen S., et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J Biol Chem 1999, 274:14560-14567.
4. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 2001, 276:4812-4818.
5. Gutierrez O., Pipaon C., Inohara N., Fontalba A., Ogura Y., Prosper F., et al. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 2002, 277:41701-41705.
6. Ogura Y., Lala S., Xin W., Smith E., Dowds T.A., Chen F.F., et al. Expression of Nod2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003, 52:1591-1597.
7. Inohara N., Ogura Y., Chen F.F., Muto A., Nunez G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J Biol Chem 2001, 276:2551-2554.
8. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., et al. Association of Nod2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
9. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., et al. A frameshift mutation in Nod2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
10. Chen G., Shaw M.H., Kim Y.G., Nunez G. Nod-like receptors: role in innate immunity and inflammatory disease. Annu Rev Pathol 2009, 4:365-398.
11. Yoneyama M., Fujita T. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 2008, 29:178-181.
12. Inohara N., Koseki T., Lin J., del Peso L., Lucas P.C., Chen F.F., et al. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem 2000, 275:27823-27831.
13. Nembrini C., Kisielow J., Shamshiev A.T., Tortola L., Coyle A.J., Kopf M., et al. The kinase activity of Rip2 determines its stability and consequently Nod1- and Nod2-mediated immune responses. J Biol Chem 2009, 284:19183-19188.
14. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., et al. Host recognition of bacterial muramyl dipeptide mediated through Nod2. Implications for Crohn's disease. J Biol Chem 2003, 278:5509-5512.
15. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003, 278:8869-8872.
16. Cossart P., Sansonetti P.J. Bacterial invasion: the paradigms of enteroinvasive pathogens. Science 2004, 304:242-248.
17. Cloud-Hansen K.A., Peterson S.B., Stabb E.V., Goldman W.E., McFall-Ngai M.J., Handelsman J. Breaching the great wall: peptidoglycan and microbial interactions. Nat Rev Microbiol 2006, 4:710-716.
18. Nigro G., Fazio L.L., Martino M.C., Rossi G., Tattoli I., Liparoti V., et al. Muramylpeptide shedding modulates cell sensing of Shigella flexneri. Cell Microbiol 2008, 10:682-695.
19. Lenz L.L., Mohammadi S., Geissler A., Portnoy D.A. SecA2-dependent secretion of autolytic enzymes promotes Listeria monocytogenes pathogenesis. Proc Natl Acad Sci USA 2003, 100:12432-12437.
20. Herskovits A.A., Auerbuch V., Portnoy D.A. Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog 2007, 3:e51.
21. Ismair M.G., Vavricka S.R., Kullak-Ublick G.A., Fried M., Mengin-Lecreulx D., Girardin H.E. hPepT1 selectively transports muramyl dipeptide but not Nod1-activating muramyl peptides. Can J Physiol Pharmacol 2006, 84:1313-1319.
22. Marina-Garcia N., Franchi L., Kim Y.G., Hu Y., Smith D.E., Boons G.J., et al. Clathrin- and dynamin-dependent endocytic pathway regulates muramyl dipeptide internalization and Nod2 activation. J Immunol 2009, 182:4321-4327.
23. Lee J., Tattoli I., Wojtal K.A., Vavricka S.R., Philpott D.J., Girardin H.E. pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J Biol Chem 2009, 284:23818-23829.
24. Barnich N., Aguirre J.E., Reinecker H.C., Xavier R., Podolsky D.K. Membrane recruitment of Nod2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition. J Cell Biol 2005, 170:21-26.
25. McDonald C., Chen F.F., Ollendorff V., Ogura Y., Marchetto S., Lecine P., et al. A role for Erbin in the regulation of Nod2-dependent NF-kappaB signaling. J Biol Chem 2005, 280:40301-40309.
26. Kufer T.A., Kremmer E., Banks D.J., Philpott D.J. Role for erbin in bacterial activation of Nod2. Infect Immun 2006, 74:3115-3124.
27. Legrand-Poels S., Kustermans G., Bex F., Kremmer E., Kufer T.A., Piette J. Modulation of Nod2-dependent NF-kappaB signaling by the actin cytoskeleton. J Cell Sci 2007, 120:1299-1310.
28. Lecine P., Esmiol S., Metais J.Y., Nicoletti C., Nourry C., McDonald C., et al. The Nod2-RICK complex signals from the plasma membrane. J Biol Chem 2007, 282:15197-15207.
29. Eitel J., Krull M., Hocke A.C., N'Guessan P.D., Zahlten J., Schmeck B., et al. Beta-PIX and Rac1 GTPase mediate trafficking and negative regulation of Nod2. J Immunol 2008, 181:2664-2671.
30. Kufer T.A., Kremmer E., Adam A.C., Philpott D.J., Sansonetti P.J. The pattern-recognition molecule Nod1 is localized at the plasma membrane at sites of bacterial interaction. Cell Microbiol 2008, 10:477-486.
31. Ea C.K., Deng L., Xia Z.P., Pineda G., Chen Z.J. Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006, 22:245-257.
32. Liew F.Y., Xu D., Brint E.K., O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005, 5:446-458.
33. Skaug B., Jiang X., Chen Z.J. The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem 2009, 78:769-796.
34. Abbott D.W., Wilkins A., Asara J.M., Cantley L.C. The Crohn's disease protein, Nod2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO. Curr Biol 2004, 14:2217-2227.
35. Hasegawa M., Fujimoto Y., Lucas P.C., Nakano H., Fukase K., Nunez G., et al. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J 2008, 27:373-383.
36. Kim J.Y., Omori E., Matsumoto K., Nunez G., Ninomiya-Tsuji J. TAK1 is a central mediator of Nod2 signaling in epidermal cells. J Biol Chem 2008, 283:137-144.
37. Windheim M., Lang C., Peggie M., Plater L.A., Cohen P. Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide. Biochem J 2007, 404:179-190.
38. Abbott D.W., Yang Y., Hutti J.E., Madhavarapu S., Kelliher M.A., Cantley L.C. Coordinated regulation of Toll-like receptor and Nod2 signaling by K63-linked polyubiquitin chains. Mol Cell Biol 2007, 27:6012-6025.
39. Bertrand M.J., Doiron K., Labbe K., Korneluk R.G., Barker P.A., Saleh M. Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors Nod1 and Nod2. Immunity 2009, 30:789-801.
40. Hsu Y.M., Zhang Y., You Y., Wang D., Li H., Duramad O., et al. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat Immunol 2007, 8:198-205.
41. Clark N.M., Marinis J.M., Cobb B.A., Abbott D.W. MEKK4 sequesters RIP2 to dictate Nod2 signal specificity. Curr Biol 2008, 18:1402-1408.
42. Tao M., Scacheri P.C., Marinis J.M., Harhaj E.W., Matesic L.E., Abbott D.W. ITCH K63-ubiquitinates the Nod2 binding protein, RIP2, to influence inflammatory signaling pathways. Curr Biol 2009, 19:1255-1263.
43. Tattoli I., Travassos L.H., Carneiro L.A., Magalhaes J.G., Girardin S.E. The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation. Semin Immunopathol 2007, 29:289-301.
44. Werts C., le Bourhis L., Liu J., Magalhaes J.G., Carneiro L.A., Fritz J.H., et al. Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway. Eur J Immunol 2007, 37:2499-2508.
45. Yamamoto-Furusho J.K., Barnich N., Xavier R., Hisamatsu T., Podolsky D.K. Centaurin beta1 down-regulates nucleotide-binding oligomerization domains 1- and 2-dependent NF-kappaB activation. J Biol Chem 2006, 281:36060-36070.
46. Bielig H., Zurek B., Kutsch A., Menning M., Philpott D.J., Sansonetti P.J., et al. A function for AAMP in Nod2-mediated NF-kappaB activation. Mol Immunol 2009, 46:2647-2654.
47. Barnich N., Hisamatsu T., Aguirre J.E., Xavier R., Reinecker H.C., Podolsky D.K., et al. GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J Biol Chem 2005, 280:19021-19026.
48. Sabbah A., Chang T.H., Harnack R., Frohlich V., Tominaga K., Dube P.H., et al. Activation of innate immune antiviral responses by Nod2. Nat Immunol 2009, 10:1073-1080.
49. Nakhaei P., Genin P., Civas A., Hiscott J. RIG-I-like receptors: sensing and responding to RNA virus infection. Semin Immunol 2009, 21:215-222.
50. Moore C.B., Bergstralh D.T., Duncan J.A., Lei Y., Morrison T.E., Zimmermann A.G., et al. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 2008, 451:573-577.
51. Ting J.P., Duncan J.A., Lei Y. How the noninflammasome NLRs function in the innate immune system. Science 2010, 327:286-290.
52. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451:1069-1075.
53. Hussey S., Travassos L.H., Jones N.L. Autophagy as an emerging dimension to adaptive and innate immunity. Semin Immunol 2009, 21:233-241.
54. Virgin H.W., Levine B. Autophagy genes in immunity. Nat Immunol 2009, 10:461-470.
55. Kaneko T., Yano T., Aggarwal K., Lim J.H., Ueda K., Oshima Y., et al. PGRP-LC and PGRP-LE have essential yet distinct functions in the drosophila immune response to monomeric DAP-type peptidoglycan. Nat Immunol 2006, 7:715-723.
56. Hofius D., Schultz-Larsen T., Joensen J., Tsitsigiannis D.I., Petersen N.H., Mattsson O., et al. Autophagic components contribute to hypersensitive cell death in Arabidopsis. Cell 2009, 137:773-783.
57. Travassos L.H., Carneiro L.A., Ramjeet M., Hussey S., Kim Y.G., Magalhaes J.G., et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010, 11:55-62.
58. Cooney R., Baker J., Brain O., Danis B., Pichulik T., Allan P., et al. Nod2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010, 16:90-97.
59. Hovanessian A.G. On the discovery of interferon-inducible, double-stranded RNA activated enzymes: the 2'-5'oligoadenylate synthetases and the protein kinase PKR. Cytokine Growth Factor Rev 2007, 18:351-361.
60. Dugan J.W., Albor A., David L., Fowlkes J., Blackledge M.T., Martin T.M., et al. Nucleotide oligomerization domain-2 interacts with 2'-5'-oligoadenylate synthetase type 2 and enhances RNase-L function in THP-1 cells. Mol Immunol 2009, 47:560-566.
61. Chisholm S.T., Coaker G., Day B., Staskawicz B.J. Host-microbe interactions: shaping the evolution of the plant immune response. Cell 2006, 124:803-814.
62. Asehnoune K., Strassheim D., Mitra S., Kim J.Y., Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 2004, 172:2522-2529.
63. Lipinski S., Till A., Sina C., Arlt A., Grasberger H., Schreiber S., et al. DUOX2-derived reactive oxygen species are effectors of Nod2-mediated antibacterial responses. J Cell Sci 2009, 122:3522-3530.
64. Tada H., Aiba S., Shibata K., Ohteki T., Takada H. Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect Immun 2005, 73:7967-7976.
65. Park J.H., Kim Y.G., Shaw M., Kanneganti T.D., Fujimoto Y., Fukase K., et al. Nod1/RICK and TLR signaling regulate chemokine and antimicrobial innate immune responses in mesothelial cells. J Immunol 2007, 179:514-521.
66. Fritz J.H., Girardin S.E., Fitting C., Werts C., Mengin-Lecreulx D., Caroff M., et al. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and Nod1- and Nod2-activating agonists. Eur J Immunol 2005, 35:2459-2470.
67. Watanabe T., Kitani A., Murray P.J., Strober W. Nod2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat Immunol 2004, 5:800-808.
68. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005, 307:731-734.
69. Kim Y.G., Park J.H., Shaw M.H., Franchi L., Inohara N., Nunez G. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. Immunity 2008, 28:246-257.
70. Ferwerda G., Girardin S.E., Kullberg B.J., Le Bourhis L., de Jong D.J., Langenberg D.M., et al. Nod2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog 2005, 1:279-285.
71. Leber J.H., Crimmins G.T., Raghavan S., Meyer-Morse N.P., Cox J.S., Portnoy D.A., et al. Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen. PLoS Pathog 2008, 4:e6.
72. Gandotra S., Jang S., Murray P.J., Salgame P., Ehrt S. Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis. Infect Immun 2007, 75:5127-5134.
73. Divangahi M., Mostowy S., Coulombe F., Kozak R., Guillot L., Veyrier F., et al. Nod2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol 2008, 181:7157-7165.
74. Raymond J.B., Mahapatra S., Crick D.C., Pavelka M.S. Identification of the namH gene, encoding the hydroxylase responsible for the N-glycolylation of the mycobacterial peptidoglycan. J Biol Chem 2005, 280:326-333.
75. Coulombe F., Divangahi M., Veyrier F., de Leseleuc L., Gleason J.L., Yang Y., et al. Increased Nod2-mediated recognition of N-glycolyl muramyl dipeptide. J Exp Med 2009, 206:1709-1716.
76. Adam A., Ciorbaru R., Ellouz F., Petit J.F., Lederer E. Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem Biophys Res Commun 1974, 56:561-567.
77. van Beelen A.J., Zelinkova Z., Taanman-Kueter E.W., Muller F.J., Hommes D.W., Zaat S.A., et al. Stimulation of the intracellular bacterial sensor Nod2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 2007, 27:660-669.
78. Magalhaes J.G., Fritz J.H., Le Bourhis L., Sellge G., Travassos L.H., Selvanantham T., et al. Nod2-dependent Th2 polarization of antigen-specific immunity. J Immunol 2008, 181:7925-7935.
79. Watts C., West M.A., Zaru R. TLR signalling regulated antigen presentation in dendritic cells. Curr Opin Immunol 2010, 22:124-130.
80. Schmid D., Pypaert M., Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007, 26:79-92.
81. Asano J., Tada H., Onai N., Sato T., Horie Y., Fujimoto Y., et al. Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo. J Immunol 2010, 184:736-745.
82. Kasturi S.P., Pulendran B. Cross-presentation: avoiding trafficking chaos?. Nat Immunol 2008, 9:461-463.
83. Shaw M.H., Reimer T., Sanchez-Valdepenas C., Warner N., Kim Y.G., Fresno M., et al. T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii. Nat Immunol 2009, 10:1267-1274.
84. Penack O., Smith O.M., Cunningham-Bussel A., Liu X., Rao U., Yim N., et al. Nod2 regulates hematopoietic cell function during graft-versus-host disease. J Exp Med 2009, 206:2101-2110.
85. Borzutzky A., Fried A., Chou J., Bonilla F.A., Kim S., Dedeoglu F. Nod2-associated diseases: Bridging innate immunity and autoinflammation. Clin Immunol 2010, 134:251-261.
86. Miceli-Richard C., Lesage S., Rybojad M., Prieur A.M., Manouvrier-Hanu S., Hafner R., et al. CARD15 mutations in Blau syndrome. Nat Genet 2001, 29:19-20.
87. Netea M.G., Kullberg B.J., de Jong D.J., Franke B., Sprong T., Naber T.H., et al. Nod2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol 2004, 34:2052-2059.
88. van Heel D.A., Ghosh S., Butler M., Hunt K.A., Lundberg A.M., Ahmad T., et al. Muramyl dipeptide and toll-like receptor sensitivity in Nod2-associated Crohn's disease. Lancet 2005, 365:1794-1796.
89. Wehkamp J., Harder J., Weichenthal M., Schwab M., Schaffeler E., Schlee M., et al. Nod2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut 2004, 53:1658-1664.
90. Kuballa P., Huett A., Rioux J.D., Daly M.J., Xavier R.J. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS One 2008, 3:e3391.
91. Maeda S., Hsu L.C., Liu H., Bankston L.A., Iimura M., Kagnoff M.F., et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005, 307:734-738.
92. Abubakar I., Myhill D., Aliyu S.H., Hunter P.R. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques, a systematic review and meta-analysis. Inflamm Bowel Dis 2008, 14:401-410.
93. Ekman A.K., Cardell L.O. The expression and function of Nod-like receptors in neutrophils. Immunology 2010, 130:55-63.
94. Stroh T., Batra A., Glauben R., Fedke I., Erben U., Kroesen A., et al. Nucleotide oligomerization domains 1 and 2: regulation of expression and function in preadipocytes. J Immunol 2008, 181:3620-3627.
95. Chauhan V., Marriott I. Differential roles for Nod2 in osteoblast inflammatory immune responses to bacterial pathogens of bone tissue. J Med Microbiol 2010.
96. Shigeoka A.A., Kambo A., Mathison J.C., King A.J., Hall W.F., da Silva Correia J., et al. Nod1 and Nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol 2010, 184:2297-2304.
97. Huzarski T., Lener M., Domagala W., Gronwald J., Byrski T., Kurzawski G., et al. The 3020insC allele of Nod2 predisposes to early-onset breast cancer. Breast Cancer Res Treat 2005, 89:91-93.
98. Forrest M.S., Skibola C.F., Lightfoot T.J., Bracci P.M., Willett E.V., Smith M.T., et al. Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br J Haematol 2006, 134:180-183.
99. Lener M.R., Oszutowska D., Castaneda J., Kurzawski G., Suchy J., Nej-Wolosiak K., et al. Prevalence of the Nod2 3020insC mutation in aggregations of breast and lung cancer. Breast Cancer Res Treat 2006, 95:141-145.